Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula
Pediatric Pulmonology · 2026
DOI: 10.1002/ppul.71814 ↗At a glance
Journal article in Pediatric Pulmonology, 2026. Written by Michelle A Mai and 2 co-authors. Institution: Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: Cannula, Immunocompromised Host, Intubation, Intratracheal, Oxygen Inhalation Therapy. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Topics: Kinderkrankenpflege
Abstract (original language)
Background
Heated, humidified, high‐flow nasal cannula (HFNC) before intubation has been associated with increased mortality in children with immunocompromising conditions (ICC).
Objectives
We sought to describe HFNC failure (intubation) rate and aimed to develop a novel score associated with HFNC failure.
Methods
This is a single center, retrospective cohort. Patients (aged 0–26 years) with ICCs who used HFNC between 2021 and 2023 were included.
Results
Forty‐four (47.3%) of 93 included subjects failed HFNC. PICU mortality was 14% ( n = 13). The median duration of HFNC was 18.7 h (IQR: 6.0, 40.4). We developed the novel FLOX ((flow in Liters/minute)/weight (kg)*FiO 2 ) score. Median FLOX score was higher with HFNC failure at initiation ( p = 0.04), 2 h ( p = 0.03), 4 h ( p = 0.05), and 6 h ( p = 0.05). Adjusting for acuity, the odds of HFNC failure with a FLOX score (≥0.20) were as follows: Initiation OR = 2.5 (95%CI: 1.03, 5.9), p = 0.042); 2 h of HFNC, OR = 4.3 ((95%CI: 1.7, 10.9), p = 0.002); 4 h of HFNC, OR = 6.5 (95%CI: 2.5, 16.8), ( p < 0.001); and 6 h of HFNC, OR = 4.9 (95%CI: 1.9, 12.7), ( p = 0.001).
Conclusion
In children with ICCs, almost half fail HFNC. Mortality was high in those who fail HFNC. The FLOX score, specifically a FLOX ≥ 0.20 is associated with increased odds of failing HFNC in our ICC cohort.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Pediatrics, Division of Critical Care, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Riley Hospital for Children at IU Health, Indianapolis, Indiana, USA.
- Regenstrief Center for Biomedical Informatics, Indianapolis, Indiana, USA.
ORCID profiles: Michelle A Mai, Colin M Rogerson, Courtney M Rowan
Funding
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Mai, M. A., Rogerson, C. M., & Rowan, C. M. (2026). Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71814
Vancouver
Mai MA, Rogerson CM, Rowan CM. Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula. Pediatric Pulmonology. 2026. doi:10.1002/ppul.71814
BibTeX
@article{Mai2026,
author = {Mai, Michelle A and Rogerson, Colin M and Rowan, Courtney M},
title = {Development of the Novel FLOX Score to Assess Risk of Intubation in Children With Immunocompromising Conditions Receiving High Flow Nasal Cannula},
journal = {Pediatric Pulmonology},
year = {2026},
doi = {10.1002/ppul.71814}
}
EUVIMED